HeartSciences Inc. (formerly Heart Test Laboratories, Inc.) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on October 11, 2024, by Heart Test Laboratories, Inc. (the "Company"). The report details a corporate name change approved by shareholders at the Annual Meeting on January 17, 2024. The Company is an emerging growth company incorporated in Texas.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate governance event and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name Change: The Company filed a Certificate of Amendment to change its name from "Heart Test Laboratories, Inc." to "HeartSciences Inc."
- Regulatory Status: The Company is awaiting confirmation from the Texas Secretary of State regarding the effectiveness of the name change.
- Securities Impact: The name change will not affect the ticker symbols (HSCS for Common Stock, HSCSW for Warrants) or the CUSIP numbers. Existing stock certificates and warrants remain valid and do not need to be exchanged.
Guidance, Outlook, and Risks
The Company expects to effect the name change in the market as soon as possible after receiving state confirmation and will separately announce the effective date. No financial guidance, management commentary on operations, or specific risk factors were disclosed in this filing.
Key Facts for Investor Verification
- Verify the official effective date of the name change to "HeartSciences Inc." once confirmed by the Texas Secretary of State.
- Confirm that trading symbols (HSCS, HSCSW) remain unchanged despite the corporate name update.
- Review the Certificate of Amendment (Exhibit 3.1) for any other potential amendments to the Certificate of Formation, though the filing states there are none.